IRIS
FOSCHI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 368
AS - Asia 288
EU - Europa 221
AF - Africa 6
OC - Oceania 2
Totale 885
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 362
SG - Singapore 207
IT - Italia 95
CN - Cina 40
DE - Germania 30
FI - Finlandia 22
FR - Francia 18
IE - Irlanda 14
IN - India 14
NL - Olanda 14
AT - Austria 11
IR - Iran 11
CA - Canada 4
ID - Indonesia 4
AE - Emirati Arabi Uniti 3
GB - Regno Unito 3
KR - Corea 3
ZA - Sudafrica 3
BG - Bulgaria 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GT - Guatemala 2
IQ - Iraq 2
SE - Svezia 2
AU - Australia 1
BE - Belgio 1
HU - Ungheria 1
IL - Israele 1
JP - Giappone 1
KZ - Kazakistan 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RO - Romania 1
TN - Tunisia 1
VN - Vietnam 1
Totale 885
Salva come PNG Salva come JPEG
Città #
Singapore 177
Boardman 132
New York 32
L’Aquila 22
West Jordan 22
Shanghai 18
Helsinki 14
Los Angeles 14
Ashburn 13
Dublin 12
Kitzingen 11
Chandler 10
Santa Clara 9
Dallas 8
Lappeenranta 8
Milan 8
Bologna 5
Pontedera 5
Ravenna 5
Mumbai 4
Pescara 4
Abu Dhabi 3
Amsterdam 3
Berlin 3
Catania 3
Fort Worth 3
Nuremberg 3
Pretoria 3
Tehran 3
Addis Ababa 2
Brno 2
Columbus 2
Del Norte 2
Gangnam-gu 2
Lambeth 2
Lucca 2
Matelica 2
Napa 2
Padova 2
Qom 2
Seriate 2
Stockholm 2
Toronto 2
Vallefoglia 2
Venice 2
Vienna 2
Atlanta 1
Auckland 1
Baghdad 1
Boydton 1
Bremen 1
Bucharest 1
Canberra 1
Chisinau 1
Des Moines 1
Dubendorf 1
Fermo 1
Florence 1
Frankfurt am Main 1
Gangbuk-gu 1
Guangzhou 1
Hamburg 1
Hanoi 1
Karbala 1
Kozhikode 1
Kunming 1
Las Vegas 1
Lawrence 1
Livorno 1
Miami 1
Montreal 1
Munich 1
Nanaimo 1
Nanjing 1
Naples 1
New Haven 1
Oakland 1
Oslo 1
Paris 1
Phoenix 1
Piscataway 1
Princeton 1
Prineville 1
Salt Lake City 1
San Mateo 1
Seattle 1
Shenzhen 1
Sofia 1
Taiyuan 1
Woodbridge 1
Zurich 1
Totale 636
Salva come PNG Salva come JPEG
Nome #
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 59
Acute stroke-like deficits associated with nonketotic hyperglycemic hyperosmolar state: an illustrative case and systematic review of literature 46
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 36
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 34
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 34
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 31
Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine 25
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis 16
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 16
Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register 16
Epidemiology and treatment of atraumatic subarachnoid hemorrhage over 10 years in a population-based registry 15
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 14
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 14
Predictors of atrial fibrillation detection in embolic stroke of undetermined source patients with implantable loop recorder 14
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 13
Comparison of Drip‐and‐Ship Versus Mothership Delivery Models of Mechanical Thrombectomy Delivery 13
Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies 13
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis 12
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease 12
Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis 12
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries 12
Sleep-related disorders and their relationship with MRI findings in multiple sclerosis 12
Sex Differences in the Epidemiology of Intracerebral Hemorrhage Over 10 Years in a Population‐Based Stroke Registry 12
Editorial: CSF and blood biomarkers in COVID-19 and other neuroinfectious diseases 11
Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31 11
Stress hyperglycemia is associated with futile recanalization in patients with anterior large vessel occlusion undergoing mechanical thrombectomy 11
Arthritic psoriasis during natalizumab treatment: a case report and review of the literature 11
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities 11
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis 11
Neurological abnormalities in individuals with Marfan syndrome: results from a genetically confirmed Italian cohort 11
Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship 11
Capsular Warning Syndrome: Features, Risk Profile, and Prognosis in a Large Prospective TIA Cohort 10
Safety and Outcomes of Mechanical Thrombectomy in Acute Ischemic Stroke Attributable to Cardiological Diseases: A Scoping Review 10
Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome 10
Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome 10
Point-Of-Care low-field MRI in acute Stroke (POCS): protocol for a multicentric prospective open-label study evaluating diagnostic accuracy 10
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 10
Teeth loss after teriflunomide treatment: Casual or causal? A short case series 10
“NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab” 9
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable 9
Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020 9
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 9
Posterior reversible encephalopathy syndrome associated with antibiotic therapy: a case report and systematic review 9
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 9
Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review 9
Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence 8
The multifaceted role of neurofilament light chain protein in non-primary neurological diseases 8
Blood GFAP as an emerging biomarker in brain and spinal cord disorders 8
A 36-Year-Old Woman With Right Eye Ptosis 8
Another Nail in the Coffin of Causality for the Diastolic Blood Pressure J Curve 8
Evaluating dalfampridine for the treatment of relapsing-remitting multiple sclerosis: does it add to the treatment armamentarium? 8
Endovascular Thrombectomy with or without Intravenous Thrombolysis for Anterior Circulation Large Vessel Occlusion in the Imperial College London Thrombectomy Registry 8
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 8
Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020 8
Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 7
Clinicoradiological Profile and Functional Outcome of Acute Cerebral Venous Thrombosis: A Hospital-Based Cohort Study 7
Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis 7
Guillain-Barré syndrome following COVID-19: new infection, old complication? 7
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study 7
Predictors of futile recanalization in nonagenarians treated with mechanical thrombectomy: a multi-center observational study 7
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 7
Enhancing stroke risk prediction in patients with transient ischemic attack: insights from a prospective cohort study implementing fast-track care 7
Diagnostic and Prognostic Blood Biomarkers in Transient Ischemic Attack and Minor Ischemic Stroke: An Up-To-Date Narrative Review 7
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 7
Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry 7
Outcomes of mechanical thrombectomy in orally anticoagulated patients with anterior circulation large vessel occlusion: a propensity-matched analysis of the Imperial College Thrombectomy Registry 7
Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study 6
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence 6
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis 6
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic 6
Postoperative outcome of body core temperature rhythm and sleep-wake cycle in third ventricle craniopharyngiomas 6
Migraine with aura, thrombophilia, and the debate on white matter hyperintensities 6
Bilateral extensive corticospinal tract lesions in MOG antibody-associated disease 6
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis 6
null 5
Outcomes of mechanical thrombectomy in acute stroke patients with atrial fibrillation detected after stroke versus known atrial fibrillation 5
Global Burden of Cardiovascular Diseases and Risks, 1990-2022 5
Disease Activity in Pregnant and Postpartum Women With Multiple Sclerosis Receiving Ocrelizumab or Other Disease-Modifying Therapies 5
Site and type of craniopharyngiomas impact differently on 24-hour circadian rhythms and surgical outcome. A neurophysiological evaluation 5
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA) 5
Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis 5
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study 5
Safety and outcomes of different endovascular treatment techniques for anterior circulation ischaemic stroke in the elderly: data from the Imperial College Thrombectomy Registry 5
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies 5
Left atrial appendage thrombosis in a patient with Friedreich Ataxia-related cardiomyopathy, left ventricular systolic dysfunction, and atrial fibrillation 4
Prospective observational cohort study of early recurrent TIA: Features, frequency, and outcome 4
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: a propensity matched analysis 4
Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis 4
The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries: a propensity-score-matched cohort study 4
Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register 4
Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases 4
A call for academic pragmatic clinical trials to address open questions in migraine prevention 4
Outcomes of different anesthesia techniques in nonagenarians treated with mechanical thrombectomy for anterior circulation large vessel occlusion: An inverse probability weighting analysis 4
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD 3
Author Response: Teaching NeuroImage: Partially Reversible Widespread Leukoencephalopathy Associated With Atypical Hemolytic Uremic Syndrome 3
Broadening the Spectrum of Adulthood X-Linked Adrenoleukodystrophy: A Report of Two Atypical Cases 3
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging - Results from the READAPT study 3
Totale 1.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.876
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.876
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 0 7 1 3
2022/202390 1 2 0 3 3 4 0 2 12 1 5 57
2023/2024391 6 10 16 47 22 47 3 3 3 85 63 86
2024/2025512 106 28 195 99 84 0 0 0 0 0 0 0
Totale 1.004